S2k-Leitlinie Nicht-alkoholische Fettlebererkrankungen – Was gibt’s Neues?

 

 Buy Article Permissions and Reprints

Zusammenfassung

Klinische Leitlinien sind für die Erfassung und Implementierung von diagnostischen und therapeutischen Standards absolut notwendig. Die nicht-alkoholischen Fettlebererkrankungen gehören mittlerweile zu den häufigsten Lebererkrankungen in den industrialisierten Ländern weltweit. Die 2015 publizierte S2k-Leitlinie der deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) vermittelt einen Überblick über die epidemiologische Situation sowie die Pathogenese und gibt evidenzbasierte Empfehlungen zu den wichtigsten Fragen der Diagnostik und Therapie bei Kindern und Erwachsenen. Hierzu wurden die aktuelle Literatur seit 2010 und relevante internationale Leitlinien sowie Expertenmeinungen in einem strukturierten Prozess ermittelt. Im Folgenden werden einige zentrale Empfehlungen der Leitlinie vorgestellt und kommentiert.

Abstract

Clinical guidelines are essential in implementing and maintaining nationwide stage-specific diagnostic and therapeutic standards. In 2015, the first German expert consensus guideline defined the evidence for epidemiology, pathogenesis, diagnosis and treatment of non-alcoholic fatty liver diseases in adults and children. The German S2k-guideline used an approved development process with de novo literature research since 2010, international guideline adaptation, or good clinical practice. Other recent evidence-based national guidelines and current references were included.

• Literatur

• 1 Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013; 10: 686-690
  CrossrefPubMedGoogle Scholar
• 2 Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World J Hepatol 2014; 6: 263-273
  CrossrefPubMedGoogle Scholar
• 3 Mensink GB, Schienkiewitz A, Haftenberger M et al. Overweight and obesity in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 786-794
  CrossrefPubMedGoogle Scholar
• 4 Kurth BM, Schaffrath RA. The prevalence of overweight and obese children and adolescents living in Germany. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 736-743
  PubMedGoogle Scholar
• 5 Schwimmer JB, Deutsch R, Kahen T et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393
  CrossrefPubMedGoogle Scholar
• 6 Gombet T, Longo-Mbenza B, Ellenga-Mbolla B et al. Aging, female sex, migration, elevated HDL-C, and inflammation are associated with prevalence of metabolic syndrome among African bank employees. Int J Gen Med 2012; 5: 495-503
  PubMedGoogle Scholar
• 7 Ratziu V, Goodman Z, Sanyal A. Current efforts and trends in the treatment of NASH. J Hepatol 2015; 62 (1 Suppl) S65-75
  CrossrefPubMedGoogle Scholar
• 8 Roeb E, Steffen HM, Bantel H et al. S2k Guideline non-alcoholic fatty liver disease. Z Gastroenterol 2015; 53: 668-723
  Article in Thieme ConnectPubMedGoogle Scholar
• 9 Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol 2013; 10: 666-675
  CrossrefPubMedGoogle Scholar
• 10 Koehler EM, Schouten JN, Hansen BE et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol 2013; 11: 1201-1204
  CrossrefPubMedGoogle Scholar
• 11 Sanyal AJ, Friedman SL, McCullough AJ et al. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. Hepatology. 2015; 61: 1392-405
  PubMedGoogle Scholar
• 12 Greten TF, Malek NP, Schmidt S et al. [Diagnosis of and therapy for hepatocellular carcinoma]. Z Gastroenterol 2013; 51: 1269-1326
  Article in Thieme ConnectPubMedGoogle Scholar